BioLineRx Ltd. (BLRX) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biolinerx Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.297 -- 00:00:04.261 Ladies and gentlemen, thank you for standing by. 00:00:04.261 -- 00:00:09.567 Welcome to the BioLineRx fourth quarter and full year 2025 financial results 00:00:09.567 -- 00:00:14.473 conference call. All participants are presently in a listen-only mode. 00:00:14.473 -- 00:00:18.678 Following management's formal presentation, instructions will begin for the question 00:00:18.678 -- 00:00:24.064 and answer session. I would now like to turn over the call to Irina Koffler, investor 00:00:24.064 -- 00:00:27.348 relations. Irina, please go ahead. 00:00:27.348 -- 00:00:30.878 Thank you, Operator, and welcome, everyone. 00:00:30.878 -- 00:00:36.566 Thank you for joining us on our annual 2025 results conference call. 00:00:36.566 -- 00:00:42.114 Earlier today, we issued a press release, a copy of which is available in the investor 00:00:42.114 -- 00:00:48.103 relations section of our website. It was also filed as a 6K. 00:00:48.103 -- 00:00:52.690 I'd like to remind you that certain statements we make during the call will be forward-looking. 00:00:52.690 -- 00:00:58.688 Because such statements deal with future events and are subject to many risks and uncertainties, 00:00:58.688 -- 00:01:03.675 Actual results may differ materially from those in the forward-looking statements. 00:01:03.675 -- 00:01:08.642 For a full discussion of these risks and uncertainties, please review our annual report 00:01:08.642 -- 00:01:13.729 on Form 20F and our quarterly reports on Form 6K 00:01:13.729 -- 00:01:18.175 that are filed to the U.S. Securities and Exchange Commission. 00:01:18.175 -- 00:01:21.640 At this time, it is now my pleasure to turn the call over to Mr. 00:01:21.640 -- 00:01:27.005 Phil Serlin, Chief Executive Officer of BioLineRx. 00:01:27.764...